More about

Epinephrine

News
July 24, 2024
3 min read
Save

Caregivers respond well after administering epinephrine during child oral food challenge

Giving young children an epinephrine autoinjection can be a positive and confidence-boosting experience for families, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
July 19, 2024
1 min read
Save

Top in allergy/asthma: Efficacy of dry powder nasal epinephrine; COVID-19 asthma outcomes

A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.

News
July 12, 2024
2 min read
Save

Top in allergy/asthma: EURneffy closer to approval; caregivers seek allergy info online

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended marketing authorization of ARS Pharmaceuticals’ EURneffy epinephrine nasal spray in the European Union, according to a press release.

News
July 09, 2024
3 min read
Save

Dry powder epinephrine nasal spray outcomes meet, surpass autoinjector delivery

A dry powder epinephrine delivered via a nasal spray yielded drug exposures that were equal to or higher than those achieved through autoinjector in a canine model, according to the results of a study performed by Belhaven Biopharma.

News
July 02, 2024
2 min read
Save

Epinephrine nasal spray recommended for approval in European Union

An epinephrine nasal spray is closer to approval in Europe, according to a press release from ARS Pharmaceuticals.

News
June 28, 2024
4 min read
Save

Epinephrine nasal spray effective, tolerable with nasal congestion

Patients with nasal congestion experienced enhanced absorption of epinephrine when it was administered via nasal spray compared with intramuscular administration, according to a study published in Annals of Allergy, Asthma & Immunology.

Clinical Guidance
Food Allergy
Treatment and Management

Food Allergy Management

Douglas H. Jones, MD, FAAAAI, FACAAI

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
April 26, 2024
1 min read
Save

Top in allergy/asthma: Neffy epinephrine nasal spray; pet allergy management

ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy epinephrine nasal spray — designed to treat type 1 allergic reactions such as anaphylaxis — by Oct. 2.

News
April 17, 2024
2 min read
Save

ARS Pharma submits response letter to FDA after further nasal epinephrine study

ARS Pharma has submitted a response letter to the FDA as it seeks approval for its neffy epinephrine nasal spray, which is designed to treat type I allergic reactions such as anaphylaxis, according to a company press release.

News
March 04, 2024
2 min read
Save

Most physicians agree that needle-free epinephrine would improve use

WASHINGTON — Most physicians believed that needle-free epinephrine delivery would be preferable among patients, and that it would lead to more patients carrying it and using it faster, survey results showed.

View more